Your browser doesn't support javascript.
loading
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.
Moradian, Negar; Gouravani, Mahdi; Salehi, Mohammad Amin; Heidari, Arash; Shafeghat, Melika; Hamblin, Michael R; Rezaei, Nima.
Afiliação
  • Moradian N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Gouravani M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Salehi MA; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Heidari A; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Shafeghat M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Hamblin MR; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, Boston, MA, 02114, USA, Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa, Network of Immunity in Infection, Malignancy and Autoimm
  • Rezaei N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, Research Center for Immunodeficiencies, Children's Medical Center, Tehran Univers
Eur Cytokine Netw ; 31(3): 81-93, 2020 Sep 01.
Article em En | MEDLINE | ID: mdl-33361013
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Fator de Necrose Tumoral alfa / Pandemias / Síndrome da Liberação de Citocina / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 / Anticorpos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Eur Cytokine Netw Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Fator de Necrose Tumoral alfa / Pandemias / Síndrome da Liberação de Citocina / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 / Anticorpos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Eur Cytokine Netw Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã